Gut bacteria play an important role in the body’s response to treatment for tuberculosis (TB), according to researchers at Weill Cornell Medicine and Memorial Sloan Kettering.
A team led by scientists at Weill Cornell Medicine has made a map identifying all the different RNA molecules that are derived from each gene in the brains of mice.
A gene linked to unusually long lifespans in humans protects brain stem cells from the harmful effects of stress, according to a new study by Weill Cornell Medicine investigators.
Common fungi, often present in the gut, teach the immune system how to respond to their more dangerous relatives, according to new research from scientists at Weill Cornell Medicine.
The discovery of an “Achilles heel” in a type of gut bacteria that causes intestinal inflammation in patients with Crohn’s disease may lead to more targeted therapies for the difficult to treat disease.
The Starr Cancer Consortium has awarded grant funding to three Weill Cornell Medicine-led multi-institution teams to advance their groundbreaking cancer research projects.
A new test for measuring the reservoir of HIV hidden in the cells of people with HIV failed to detect this reservoir in a significant number of people with a subtype of HIV-1, according to a study from scientists at Weill Cornell Medicine, Simon Fraser University and the British Columbia Centre for Excellence in HIV/AIDS.
Mutations in proteins called histone H1, which help package DNA in chromosomes, are a frequent cause of lymphomas, according to a study led by researchers at Weill Cornell Medicine, NewYork-Presbyterian and The Rockefeller University. The findings could lead to new approaches to treating these cancers.
Space travel, illnesses like COVID-19, and climbing Mount Everest can trigger the body’s stress response systems in similar ways, according to new studies by Weill Cornell Medicine, space agencies and many other investigators.
Common symptoms of the genetic disorder neurofibromatosis type 1 (NF1), including skeletal fragility and the loss of bone mass, may be treatable with an existing anti-cancer drug, according to a study from researchers at Weill Cornell Medicine.
A code discovered in DNA packaging proteins enables the rapid expression of genes needed to fight immediate threats, a finding that may pave the way for new treatments for cancer and inflammatory diseases.
Like more than half of Weill Cornell Medicine’s Class of 2020, Dr. Kevin Ackerman chose to graduate early to be of service to New York City’s healthcare system during the COVID-19 pandemic.
Graduate school alumni have been recognized with this award since 1997 for their outstanding contributions to biomedical research in education, focusing on science and scholarship, leadership, mentoring and teaching, and service to society.
The Weill Cornell Graduate School of Medical Sciences honored the Class of 2020 for their academic achievements during a virtual convocation ceremony on May 27. Students and their families and friends watched a livestream of the event, as graduate school faculty announced the recipients of special awards and prizes.
The prospect of residency typically brings jitters to newly minted doctors as they prepare to start the next phase of their medical training, and the level and scope of their patient care responsibilities increases. But the transition has become far more complex with numerous unknowns surrounding the ongoing COVID-19 pandemic.
Dr. Rache Simmons, associate dean for diversity and inclusion at Weill Cornell Medicine, has been named one of Crain’s inaugural Notable Women in Talent Resources in the Greater New York City area.
The fourth annual NYC Health Hackathon brought together students and faculty members from Weill Cornell Medicine, Cornell’s Ithaca campus and several local and national academic institutions, to develop high-tech healthcare innovations.
Dr. Barbara Hempstead, dean of the Weill Cornell Graduate School of Medical Sciences, has been awarded Weill Cornell Medicine’s Joan and Sanford I. Weill Exemplary Achievement Award.
